2.94% -0.0209

Dopo l'orario di chiusura: .66 -0.0291 -4.22%

Novabay Pharmaceuticals Inc (NBY)

Novabay Pharmaceuticals Inc Borsa (NBY) Ultime notizie

Novabay Pharmaceuticals Inc (NBY)

Novabay Pharmaceuticals Inc Borsa (NBY) Ultime notizie

NovaBay Pharmaceuticals Signs Definitive Agreement to Sell Its Avenova Assets - Vision Monday

Novabay Pharmaceuticals Inc (NBY) Stock: A Year of Market Fluctuations - The InvestChronicle

Before You Invest, Make Sure You Check This Novabay Pharmaceuticals Inc (AMEX: NBY) Analysis - Stocks Register

Novabay Pharmaceuticals Inc (NBY)’s Market Momentum: Closing Strong at 0.70, Down -5.62 - The Dwinnex

NovaBay Pharmaceuticals, Inc. announced that it expects to receive $2.83 million in funding from Pioneer Pharma Pte. Ltd. and other investors. - Marketscreener.com

A new trading data show Novabay Pharmaceuticals Inc (NBY) is showing positive returns. - SETE News

NovaBay Pharmaceuticals (NYSE:NBY) Now Covered by StockNews.com - Defense World

What's Going On With NovaBay Pharmaceuticals Shares Friday? - Benzinga

NBY’s price-to-free cash flow ratio: What it means for investors - US Post News

NovaBay sells Avenova brand to PRN for $9.5 million - Investing.com

PRN Nutriceuticals agreed to acquire Assets of Avenova Brand and Business of NovaBay Pharmaceuticals, Inc.. - Marketscreener.com

NBY Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of NovaBay Pharmaceuticals, Inc.’s Avenova Brand and Business Is Fair to Shareholders - Business Wire

NovaBay sells Avenova brand to PRN for $9.5 million By Investing.com - Investing.com South Africa

NovaBay Pharma Announces Avenova Sale and Planned Dissolution - TipRanks

Acumen Health Holdings ("Acumen") to Acquire the Avenova brand from NovaBay Pharmaceuticals - StockTitan

NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets - StockTitan

NovaBay Pharmaceuticals (NYSE:NBY) Earns Hold Rating from Analysts at StockNews.com - Defense World

Impetigo Drugs Global Strategic Business Report 2024 - GlobeNewswire Inc.

Was there any good news for Novabay Pharmaceuticals Inc (NBY) stock in the last session? - US Post News

Novabay Pharmaceuticals Inc Inc. (NBY) Price Performance: The Role of Supply and Demand - The InvestChronicle

NovaBay Pharmaceuticals (NYSE:NBY) Announces Quarterly Earnings Results - Defense World

NovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q2 2024 Earnings Call Transcript - Insider Monkey

Novabay Pharmaceuticals Inc (NBY)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex

NovaBay Pharmaceuticals Reports Mixed Second Quarter 2024 Financial Results - Vision Monday

Earnings call: NovaBay Pharmaceuticals reports growth in eyecare By Investing.com - Investing.com Canada

Earnings call: NovaBay Pharmaceuticals reports growth in eyecare - Investing.com

NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Stock Crosses Above 50-Day Moving Average of $0.00 - Defense World

NovaBay To Hold 2017 Second Quarter Conference Call On August 10, 2017 - BioSpace

NBY Stock Earnings: NovaBay Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024 - InvestorPlace

NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results - wallstreet:online

NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results - StockTitan

Ratio Analysis: Unpacking Novabay Pharmaceuticals Inc (NBY)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

NBY’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle

NovaBay stock hits 52-week low at $0.47 amid steep annual decline - Investing.com

NovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering - Vision Monday

NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024 - StockTitan

NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024 - Business Wire

Adversity is less terrifying than hope: Novabay Pharmaceuticals Inc (NBY) - SETE News

NovaBay reports surge in Avenova sales during Prime Day - Investing.com

NovaBay reports surge in Avenova sales during Prime Day By Investing.com - Investing.com Canada

NBYNovaBay Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan

Novabay Pharmaceuticals Inc (NBY) shows promising results - US Post News

NovaBay Pharmaceuticals Reports Record Amazon Prime Day Sales - StockTitan

NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) Short Interest Update - American Banking and Market News

What's Going On With NovaBay Pharmaceuticals (NBY) Stock? - Benzinga

NovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment Option - StockTitan

NBY’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - The InvestChronicle

NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) Short Interest Up 27.0% in July - Defense World

NovaBay Pharmaceuticals (AMEX:NBY) Stock Quotes, Forecast and News Summary - Benzinga

Why NovaBay Pharmaceuticals (NBY) Stock Is Down 60% - Benzinga

NovaBay Pharmaceuticals announces public offering of common stock and warrants - Investing.com Nigeria

NovaBay Pharmaceuticals announces public offering of common stock and warrants - Investing.com

Dow Surges 550 Points; Headline PCE Price Index Falls To 2.5% - Benzinga

NovaBay Pharmaceuticals announces pricing of $3.5M underwritten offering - MSN

NovaBay Pharmaceuticals Announces Pricing of $3.5 Million Underwritten Public Offering - Business Wire

NovaBay Pharmaceuticals (NYSE:NBY) Stock Price Up 1.4% - Defense World

NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Share Price Passes Above Fifty Day Moving Average of $0.00 - Defense World

NovaBay slashes prices on eyecare products for Amazon Prime Day By Investing.com - Investing.com Canada

NovaBay slashes prices on eyecare products for Amazon Prime Day - Investing.com

NovaBay slashes prices on eyecare products for Amazon Prime Day - Investing.com India

NovaBay Pharmaceuticals Offers 20% Discounts on Avenova Eyecare Products During Amazon Prime Day - StockTitan

Blepharitis Treatment Market to Witness Huge Growth by 2031 | Thea Pharmaceuticals Ltd., Biogen Inc., Pfizer Inc., NovaBay Pharmaceuticals, Inc. – TIMC - TIMC

NovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 Million - Vision Monday

Simile a NBY